Skip to main content
Top
Published in: Clinical and Translational Oncology 11/2019

01-11-2019 | Ultrasound | Research Article

Role of multi-modality functional imaging in differentiation between benign and malignant thyroid 18F-fluorodeoxyglucose incidentaloma

Authors: H. Shi, Z. Yuan, C. Yang, J. Zhang, C. Liu, J. Sun, X. Ye

Published in: Clinical and Translational Oncology | Issue 11/2019

Login to get access

Abstract

Purpose

To evaluate the diagnostic performance of multi-modality functional imaging in differentiating malignant and benign thyroid 18F-fluorodeoxyglucose (18F-FDG) incidentaloma.

Methods

This study included 87 patients with thyroid 18F-FDG incidentalomas detected by 18F-FDG- positron emission tomography/computed tomography (18F-FDG-PET/CT) and diagnosed at surgery or biopsy, who received 18F-FDG-PET/CT, diffusion-weighted MR imaging (DWI) and ultrasound elastography (USE). The metabolic tumor volume (MTV), total lesion glycolysis (TLG), apparent diffusion coefficient (ADC) values and ultrasound elasticity scores of thyroid 18F-FDG incidentalomas were measured and compared in benign and malignant thyroid incidentalomas. The differences of malignant and benign thyroid incidentalomas were tested by χ2 test, Fisher’s exact test, t test, or Mann–Whitney U test. The diagnostic performance was evaluated and optimal cut-off values were determined in distinguishing malignant from benign thyroid incidentalomas by receiver operating characteristic curve analysis.

Results

MTV, TLG and USE scores of malignant thyroid incidentalomas were significantly higher than benign; but ADC value was significantly lower. We defined the functional imaging parameters TLG < 2.48, ADC > 1.80 × 10−3mm2/s, and USE score of 1 as markers of benign thyroid incidentalomas and each scored -1 point; TLG ≥ 2.48, ADC ≤ 1.80 × 10−3mm2/s, and USE score of 4 as markers of malignancy and each scored 1 point. Combined multi-functional imaging parameters achieved the highest performance (84.6% sensitivity and 97.1% specificity) for distinguish malignant from benign thyroid incidentaloma with AUC 0.957 (95% CI 0.917, 0.997).

Conclusions

Functional imaging might help to distinguishing malignant from benign thyroid 18F-FDG incidentalomas, and combined multi-functional imaging parameters could improve it.
Literature
1.
go back to reference Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin N Am. 2000;29:187–203.CrossRef Burguera B, Gharib H. Thyroid incidentalomas. Prevalence, diagnosis, significance, and management. Endocrinol Metab Clin N Am. 2000;29:187–203.CrossRef
2.
go back to reference Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol. 2001;2:157–64.CrossRef Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol. 2001;2:157–64.CrossRef
3.
go back to reference Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, Shen YY, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res. 2005;25:1421–6.PubMed Chen YK, Ding HJ, Chen KT, Chen YL, Liao AC, Shen YY, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res. 2005;25:1421–6.PubMed
4.
go back to reference Bakshi NA, Mansoor I, Jones BA. Analysis of inconclusive fine-needle aspiration of thyroid follicular lesions. Endocr Pathol. 2003;14:167–75.CrossRef Bakshi NA, Mansoor I, Jones BA. Analysis of inconclusive fine-needle aspiration of thyroid follicular lesions. Endocr Pathol. 2003;14:167–75.CrossRef
5.
go back to reference Tollin SR, Mery GM, Jelveh N, Fallon EF, Mikhail M, Blumenfeld W, et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid. 2000;10:235–41.CrossRef Tollin SR, Mery GM, Jelveh N, Fallon EF, Mikhail M, Blumenfeld W, et al. The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter. Thyroid. 2000;10:235–41.CrossRef
6.
go back to reference Ríos A, Rodríguez JM, Galindo PJ, Montoya M, Tebar FJ, Sola J, et al. Utility of fine-needle aspiration for diagnosis of carcinoma associated with multinodular goitre. Clin Endocrinol (Oxf). 2004;61:732–7.CrossRef Ríos A, Rodríguez JM, Galindo PJ, Montoya M, Tebar FJ, Sola J, et al. Utility of fine-needle aspiration for diagnosis of carcinoma associated with multinodular goitre. Clin Endocrinol (Oxf). 2004;61:732–7.CrossRef
7.
go back to reference Azizi G, Keller J, Lewis M, Puett D, Rivenbark K, Malchoff C. Performance of elastography for the evaluation of thyroid nodules: a prospective study. Thyroid. 2013;23:734–40.CrossRef Azizi G, Keller J, Lewis M, Puett D, Rivenbark K, Malchoff C. Performance of elastography for the evaluation of thyroid nodules: a prospective study. Thyroid. 2013;23:734–40.CrossRef
8.
go back to reference Van de Wiele C, Kruse V, Smeets P, Sathekge M, Maes A. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. Eur J Nucl Med Mol Imaging. 2013;40:290–301.CrossRef Van de Wiele C, Kruse V, Smeets P, Sathekge M, Maes A. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours. Eur J Nucl Med Mol Imaging. 2013;40:290–301.CrossRef
9.
go back to reference Erdem G, Erdem T, Muammer H, Mutlu DY, Firat AK, Sahin I, et al. Diffusion-weighted images differentiate benign from malignant thyroid nodules. J Magn Reson Imaging. 2010;31:94–100.CrossRef Erdem G, Erdem T, Muammer H, Mutlu DY, Firat AK, Sahin I, et al. Diffusion-weighted images differentiate benign from malignant thyroid nodules. J Magn Reson Imaging. 2010;31:94–100.CrossRef
10.
go back to reference Tezelman S, Giles Y, Tunca F, Gok K, Poyanli A, Salmaslioglu A, et al. Diagnostic value of dynamic contrast medium enhanced magnetic resonance imaging in preoperative detection of thyroid carcinoma. Arch Surg. 2007;142:1036–41.CrossRef Tezelman S, Giles Y, Tunca F, Gok K, Poyanli A, Salmaslioglu A, et al. Diagnostic value of dynamic contrast medium enhanced magnetic resonance imaging in preoperative detection of thyroid carcinoma. Arch Surg. 2007;142:1036–41.CrossRef
11.
go back to reference Shi H, Yuan Z, Yuan Z, Yang C, Zhang J, Shou Y, et al. Diagnostic value of volume-based fluorine-18-fluorodeoxyglucose PET/CT parameters for characterizing thyroid incidentaloma. Korean J Radiol. 2018;19:342–51.CrossRef Shi H, Yuan Z, Yuan Z, Yang C, Zhang J, Shou Y, et al. Diagnostic value of volume-based fluorine-18-fluorodeoxyglucose PET/CT parameters for characterizing thyroid incidentaloma. Korean J Radiol. 2018;19:342–51.CrossRef
12.
go back to reference Bhatia KS, Rasalkar DP, Lee YP, Wong KT, King AD, Yuen HY, et al. Cystic change in thyroid nodules: a confounding factor for real-time qualitative thyroid ultrasound elastography. Clin Radiol. 2011;66:799–807.CrossRef Bhatia KS, Rasalkar DP, Lee YP, Wong KT, King AD, Yuen HY, et al. Cystic change in thyroid nodules: a confounding factor for real-time qualitative thyroid ultrasound elastography. Clin Radiol. 2011;66:799–807.CrossRef
13.
go back to reference Rubaltelli L, Corradin S, Dorigo A, Stabilito M, Tregnaghi A, Borsato S, et al. Differential diagnosis of benign and malignant thyroid nodules at elastosonography. Ultraschall Med. 2009;30:175–9.CrossRef Rubaltelli L, Corradin S, Dorigo A, Stabilito M, Tregnaghi A, Borsato S, et al. Differential diagnosis of benign and malignant thyroid nodules at elastosonography. Ultraschall Med. 2009;30:175–9.CrossRef
14.
go back to reference Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf). 2011;75:528–34.CrossRef Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf). 2011;75:528–34.CrossRef
15.
go back to reference Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDGPET/CT thyroid incidentalomas. J Clin Endocrinol Metab. 2012;97:3866–75.CrossRef Bertagna F, Treglia G, Piccardo A, Giubbini R. Diagnostic and clinical significance of F-18-FDGPET/CT thyroid incidentalomas. J Clin Endocrinol Metab. 2012;97:3866–75.CrossRef
16.
go back to reference Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, et al. Diagnostic value of metabolic tumor volume assessed by 18F-FDG-PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Nucl Med Commun. 2013;34:868–76.PubMed Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, et al. Diagnostic value of metabolic tumor volume assessed by 18F-FDG-PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma. Nucl Med Commun. 2013;34:868–76.PubMed
17.
go back to reference Ho TY, Liou MJ, Lin KJ, Yen TC. Prevalence and significance of thyroid uptake detected by 18F FDG PET. Endocrine. 2011;40:297–302.CrossRef Ho TY, Liou MJ, Lin KJ, Yen TC. Prevalence and significance of thyroid uptake detected by 18F FDG PET. Endocrine. 2011;40:297–302.CrossRef
18.
go back to reference Kim SJ, Chang S. Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results. Endocrine. 2015;50:681–8.CrossRef Kim SJ, Chang S. Predictive value of intratumoral heterogeneity of F-18 FDG uptake for characterization of thyroid nodules according to Bethesda categories of fine needle aspiration biopsy results. Endocrine. 2015;50:681–8.CrossRef
19.
go back to reference Noda Y, Kanematsu M, Goshima S, Kondo H, Watanabe H, Kawada H, et al. MRI of the thyroid for differential diagnosis of benign thyroid nodules and papillary carcinomas. AJR Am J Roentgenol. 2015;204:W332–W33535.CrossRef Noda Y, Kanematsu M, Goshima S, Kondo H, Watanabe H, Kawada H, et al. MRI of the thyroid for differential diagnosis of benign thyroid nodules and papillary carcinomas. AJR Am J Roentgenol. 2015;204:W332–W33535.CrossRef
20.
go back to reference Sasaki M, Sumi M, Kaneko K, Ishimaru K, Takahashi H, Nakamura T. Multiparametric MR imaging for differentiating between benign and malignant thyroid nodules: initial experience in 23 patients. J Magn Reson Imaging. 2013;38:64–71.CrossRef Sasaki M, Sumi M, Kaneko K, Ishimaru K, Takahashi H, Nakamura T. Multiparametric MR imaging for differentiating between benign and malignant thyroid nodules: initial experience in 23 patients. J Magn Reson Imaging. 2013;38:64–71.CrossRef
21.
go back to reference Hao Y, Pan C, Chen W, Li T, Zhu W, Qi J. Differentiation between malignant and benign thyroid nodules and stratification of papillary thyroid cancer with aggressive histological features: whole-lesion diffusion-weighted imaging histogram analysis. J Magn Reson Imaging. 2016;44:1546–55.CrossRef Hao Y, Pan C, Chen W, Li T, Zhu W, Qi J. Differentiation between malignant and benign thyroid nodules and stratification of papillary thyroid cancer with aggressive histological features: whole-lesion diffusion-weighted imaging histogram analysis. J Magn Reson Imaging. 2016;44:1546–55.CrossRef
22.
go back to reference Lyshchik A, Higashi T, Asato R, Tanaka S, Ito J, Mai JJ, et al. Thyroid gland tumor diagnosis at US elastography. Radiology. 2005;237:202–11.CrossRef Lyshchik A, Higashi T, Asato R, Tanaka S, Ito J, Mai JJ, et al. Thyroid gland tumor diagnosis at US elastography. Radiology. 2005;237:202–11.CrossRef
23.
go back to reference Sebag F, Vaillant-Lombard J, Berbis J, Griset V, Henry JF, Petit P, et al. Shear wave elastography: a new ultrasound imaging mode for the differential diagnosis of benign and malignant thyroid nodules. J Clin Endocrinol Metab. 2010;95:5281–8.CrossRef Sebag F, Vaillant-Lombard J, Berbis J, Griset V, Henry JF, Petit P, et al. Shear wave elastography: a new ultrasound imaging mode for the differential diagnosis of benign and malignant thyroid nodules. J Clin Endocrinol Metab. 2010;95:5281–8.CrossRef
Metadata
Title
Role of multi-modality functional imaging in differentiation between benign and malignant thyroid 18F-fluorodeoxyglucose incidentaloma
Authors
H. Shi
Z. Yuan
C. Yang
J. Zhang
C. Liu
J. Sun
X. Ye
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology / Issue 11/2019
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02089-9

Other articles of this Issue 11/2019

Clinical and Translational Oncology 11/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine